Predicting the Efficacy of Novel Synthetic Compounds in the Treatment of Osteosarcoma via Anti-Receptor Activator of Nuclear Factor- κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Targets

CONCLUSION: The analytic scrutiny of both algorithms underscores their commendable reliability in forecasting the efficacy of nascent compounds. A juxtaposition based on correlation coefficients elucidates that the GEP algorithm exhibits superior predictive prowess relative to the HM algorithm for novel synthetic compounds.PMID:38468522 | DOI:10.2174/0115734064287922240222115200
Source: Medicinal Chemistry - Category: Chemistry Authors: Source Type: research